Imam Abdulrahman Bin Faisal University
iau.edu.saLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
87
Active
10
Phase 3
8
Total enrollment
8,329
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Desmopresin | — | — | — | — | — | 1 | |
| Sodium Chloride (NaCl) 0.9 % | — | — | — | — | — | 1 |
Next readouts
- 2027-07
- 2028-08
Top conditions
- Postoperative Pain3
- Low Back Pain3
- Nonspecific Neck Pain2
- Lung Diseases2
- Cardiac Surgery2
- Neck Pain2
- Plantar Fasciitis2
- Obesity2
Frequently asked questions about Imam Abdulrahman Bin Faisal University
- How many clinical trials does Imam Abdulrahman Bin Faisal University have on ClinicalTrials.gov?
- Imam Abdulrahman Bin Faisal University is listed as the lead sponsor on 87 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Imam Abdulrahman Bin Faisal University's trials are in Phase 3?
- 8 of Imam Abdulrahman Bin Faisal University's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Imam Abdulrahman Bin Faisal University focus on?
- Imam Abdulrahman Bin Faisal University's most-studied conditions on ClinicalTrials.gov are Postoperative Pain, Low Back Pain, Nonspecific Neck Pain, Lung Diseases, Cardiac Surgery.
- When are Imam Abdulrahman Bin Faisal University's next clinical trial readouts?
- Imam Abdulrahman Bin Faisal University has 2 upcoming primary-completion readouts tracked here; the soonest is “Transfusion Reduction in High-Bleeding-Risk Cardiac Surgery With Desmopressin”, expected around 2027-07.